Gene therapy for coronary disease

Annales d'Endocrinologie

Volumn 61, Issue 1, 2000, Pages 85-90

  Stephan, D ^a   Weltin, D ^a   Zaric, V ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Angiogenesis; Gene transfer; Restenosis

Indexed keywords

VIRUS VECTOR;

CARDIOVASCULAR DISEASE; CELL DIVISION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FOREIGN BODY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; RESTENOSIS; THROMBOSIS; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; CORONARY VESSELS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0034013288     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998 ; 97 : 1114-23.
2. Belle EV, Tio F, Chen D et al. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 1997 ; 29 : 1371-9.
3. Boussif O, Lezoualc'h F, Zanta M et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo : polyethylenimine. Proc Natl Acad Sci USA 1993 ; 92 : 7297-301.
4. Chang M, Barr E, Lu M, Barton K, Leiden J. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995 ; 96 : 2260-8.
5. Chang M, Barr E, Seltzer J et al. Cytostatic gene therapy for vas-cular proliferative disorders with a constituvely active form of the retinoblastoma gene product. Science 1995 ; 267 : 518-22.
6. Chang M, Ohno T, Gordon D et al. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol Med 1995 ; 1 : 172-81.
7. Dunn P, Newman K, Jones M et al. Seeding of vascular grafts with genetically modified endothelial cells : secretion of recombinant tPA results in decreased seeded cell retention in vitro and in vivo. Circulation 1996 ; 93 : 1439-46.
8. Feldman L, Steg P, Zheng L et al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 1995 ; 95 : 2662-71.
9. Felgner P, Ringold G. Cationic liposome-mediated transfection. Nature 1989 ; 337 : 387-8.
10. Fischman D, Leon M, Baim D et al. A randomized comparison of cononary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994 ; 331 : 496-501.
11. Guagov S, Weisenberg E, Zarins C, Stankunavicius R, Kolettis G. Compensatory enlargment of human atherosclerotic coronary arteries. N Engl J Med 1987 ; 316 : 1371-5.
12. Harrell R, Rajanayagam S, Doanes A et al. Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 1997 ; 96 : 621-7.
13. Indolf C, Avvedimento E, Rapacciuolo A et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1995 ; 1 : 541-5.
14. Landau C, Lange R, Hillis L. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994 ; 330 : 981-93.
15. Lemarchand P, Jones M, Yamada I, Crystal R. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993 ; 72 : 1132-8.
16. Leyen HVD, Gibbons G, Morishita R et al. Gene therapy inhibiting neointimal vascular lesion : in vivo tranfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995 ; 92 : 1137-41.
17. Losordo DW, Vale PR, Symes JF et al. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998 ; 98 : 2800-4.
18. Morishita R, Gibbons G, Ellison K et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994 ; 93 : 1458-64.
19. Morishita R, Gibbons G, Kaneda Y, Ogihara T, Dzau V. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 1993 ; 91 : 2580-5.
20. Mulhauser J, Merrill M, Pili R et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995 ; 77 : 1077-86.
21. Nabel E. Direct gene transfer into the arterial wall. J Vasc surg 1992 ; 15 : 931-2
22. Nabel E, Gordon D, Yang Z et al. Gene transfer in vivo with DNA-liposome complexes : lack of autoimmunity and gonadal localization. Hum Gene Ther 1992 ; 3 : 649-56.
23. Nabel E, Plautz G, Boyce F, Stanley G. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989 ; 244 : 1342-4.
24. Nabel E, Plautz G, Nabel G. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990 ; 249 : 1285-8.
25. Nabel E, Plautz G, Nabel G. Transduction of a foreing histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci USA 1992 ; 89 : 5157-61.
26. Ohno T, Gordon D, San H et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994 ; 265 : 781-4.
27. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry J, Isner J. Arterial gene transfer using pure DNA applied directly to a hydrogelcoated angioplasty balloon. Hum Gene Ther 1993 ; 4 : 749-58.
28. Schwartz R, Holmes D, Topol E. The restenosis paradigm revisited : an alternative proposal for cellular mechanisms. J Am Coll Cardial 1992 ; 20 : 1284-93.
29. Serruys P, Jaegere PD, Kiemeneij F et al. A comparison of ballon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994 ; 331 : 489-95.
30. Shi Y, Fard A, Vermani P, Zalewski A. Transgene expression in the coronary circulation : transcatheter gene delivery. Gene Ther 1994 ; 1 : 408-14.
31. Simari R, San H, Rekhter M et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 1996 ; 98 : 225-35.
32. Smith R, Branellec D, Gorski D et al. p21CIPI-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev 1997 ; 11 : 1674-89.
33. Steg P, Feldman L, Scoazec J et aL. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of a adenoviral vector. Circulation 1994 ; 90 : 1648-56.
34. Stephan D, Nabel E. Gene and other biological therapies for vascular diseases. Fundam Clin Pharmacol 1997 ; 11 : 97-110.
35. Stephan D, Yang Z, San H et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996 ; 7 : 1803-12.
36. Stewart M, Plautz G, Del BL et al. Gene transfer in vivo with DNA-liposome complexes : safety and acute toxicity in mice. Hum Gene Ther 1992 ; 3 : 267-75.
37. Takeshita S, Pu L, Stein L et al. Intramuscular administration of vascular endothelium growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994 ; 90 : 11-228-1134.
38. Wilson J. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996 ; 334 : 1185-7.
39. Yang Z, Simari R, Perkins N et al. Role of the p21 cydin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 1996 ; 93 : 7905-10.